Live Biotherapeutic Products and microbiome programs
From process development to GMP drug product, Biose Industrie delivers complete CDMO solutions for Live Biotherapeutic Products and microbiome programs.
Process Development
- Anaerobic and aerobic expertise – nearly 800 different strains produced
- Co-culture expertise - upto 130-strain broas spectrum projects
- Upstream optimisation and downstream processing
- Analytical development, method qualification, and stability studies
GMP Drug Substance Manufacturing
- Fermentation from 5L to 5,000 L
- Clinical-to-commercial scale readiness
- High-consistency, high-viability DS output
- State of the art GMP suites fully sealed from Innoculation to Lyophilisation for anaerobic or aerobic strains
GMP Drug Product Manufacturing
- Capsules, tablets, sachets, vials, creams and oils
- Formulation and clinical and commercial capacity in fully controlled environments
- Blistering & Bottling
- Packaging & Labelling
- Cold-chain logistics
Tech Transfer
- 250 m² tech transfer and phase I manufacturing near Boston
- Fast onboarding and industrialisation support
- Full one stop service at our Microbiome centre of excellence in France
Discover the potential of microbiome therapeutics.
Explore our innovative solutions in Live Biotherapeutic Products (LBPs) and Next Generation Probiotics, from development through GMP manufacturing.
Learn more about our next-generation therapies.